News
News

The latest updates from AFAR.

Grantee in the News: David Sinclair Named to TIME Magazine’s 100 Most Influential People

Apr 25
2014

Grantee in the News: David Sinclair Named to TIME Magazine’s 100 Most Influential People

  AFAR would like to extend a big congratulations to 2000 AFAR Research Award Grantee David A. Sinclair, PhD, for being named one of TIME Magazine’s 2014 100 Most Influential People! Dr. Sinclair’s research focuses primarily on identifying ways to enhance the body’s natural ability to cure diseases.  He is working on uncovering how the Sirtuin genes protect against aging and diseases.  Dr. Sinclair serves as a Professor of Genetics and co-Director of the Paul F. Glenn Laboratories for the Biological Mechanisms of Aging at Harvard Medical School.  AFAR is thrilled to see…


View MoreREAD MORE


Join Us for the 2014 MetLife Foundation Awards for Medical Research!

Apr 24
2014

Join Us for the 2014 MetLife Foundation Awards for Medical Research!

  AFAR invites you to join us for the 2014 MetLife Foundation Awards for Medical Research ceremony and reception. Now in their 28th year, The MetLife Awards recognize major scientific contributions that have promoted a better understanding of the underlying causes, prevention, and treatments of Alzheimer’s disease.  This year’s award ceremony will be held on Thursday, May 15th from 3-5pm at the MetLife Building in New York City.  The program includes a research briefing followed by presentation of the Major Awards and a Promising Research award, totaling $600,000. The keynote speaker will be Mark Shriver,…


View MoreREAD MORE


Grantee in the News: Kim Green Uncovers New Brain Finding in AFAR Funded Study

Apr 23
2014

Grantee in the News: Kim Green Uncovers New Brain Finding in AFAR Funded Study

On April 16, 2014 Neuron Journal published results of 2013 New Investigator in Alzheimer’s Disease grantee Kim Green, PhD’s, groundbreaking study, which was partially funded by AFAR.  Dr. Green’s research examined the role neuroinflammation plays in neurodegenerative diseases, such as Alzheimer’s disease and Parkinson’s disease.  In a study performed on wild mice, Dr. Green removed all of the brain’s main immunity defense cells, microglia, through the use of a molecule inhibitor.  Dr. Green and his team found that once the inhibitor was removed a new set of…


View MoreREAD MORE


Scholar in the News: Centers of Excellence Scholar Gary Epstein-Lubow in The Washington Post

Apr 15
2014

Scholar in the News: Centers of Excellence Scholar Gary Epstein-Lubow in The Washington Post

On April 14th, 2014 AFAR Center of Excellence Scholar and geriatric psychiatrist, Gary Epstein-Lubow, MD, contributed a piece to The Washington Post opening up on how dementia effected his family after his mother-in-law was diagnosed with the disease.   Dr. Epstein-Lubow shined light on the forgotten victims of dementia, the caregivers and loved ones of those diagnosed. Dr. Epstein-Lubow especially noted that the estimated 15 million unpaid caregivers in the United States have a higher risk for homicide and suicide and experience depression at a rate 2-3 times above that of the general population. Gary Epstein-Lubow, MD, is geriatric psychiatrist…


View MoreREAD MORE


CoE Scholar in the News: Valerie Wilson, MD, Examines Vitamin D Deficiency and Cognition in Seniors

Apr 15
2014

CoE Scholar in the News: Valerie Wilson, MD, Examines Vitamin D Deficiency and Cognition in Seniors

On April 15, 2014, 2012 AFAR Center of Excellence Scholar, Valerie Wilson, MD, recently published her research on vitamin D deficiency and cognition in older adults in the latest issue of the journal of the American Geriatrics Society. By comparing the vitamin D levels and cognitive ability of 2,777 adults ages 70-79 twice during a four year study, Dr. Wilson and her team found evidence of an association between low vitamin D levels and cognitive decline over time. While further research is need to determine whether vitamin D and cognation have a dependent relationship, there would be huge public health implantations if vitamin D…


View MoreREAD MORE


Grantee in the News: Ted Dawson Identifies Biological Process that Triggers Parkinson’s Disease

Apr 10
2014

Grantee in the News: Ted Dawson Identifies Biological Process that Triggers Parkinson’s Disease

On April 10th, 2014, Fox News profiled AFAR 1995 Beeson Scholar Dr. Ted Dawson’s new research  identifying a protein trigger for a common form of Parkinson’s disease.  Dr. Dawson, along with his team and John Hopkins University, built on research linking mutations in the enzyme, LRRK2, with the onset of Parkinson’s disease, by uncovering the protein LRRK2 acts on, s15. Identification of this protein and enzyme combination is significant because it may lead to earlier diagnosis and better treatment for Parkinson’s disease. Ted Dawson, MD, PhD, is a professor at John…


View MoreREAD MORE


Industry News: Canine Longevity and the Old Grey Muzzle Tour

Apr 07
2014

Industry News: Canine Longevity and the Old Grey Muzzle Tour

AFAR is proud to be a sponsor of The Old Grey Muzzle Tour, a scientific expedition to discover the secrets of successful aging and cancer avoidance through canine research, led by Director David J. Waters, DVM, PhD. Since February 2014, Dr. Waters has embarked on a 50-day, cross-country journey to research 17 of the oldest-living Rottweiler dogs in the United States. AFAR applauds Dr. Waters’ inventive research and creative approach to raising awareness for what we can learn about human aging by studying canine aging. AFAR’s Scientific Director, Steven Austad, PhD, states “It’s amazing to me…


View MoreREAD MORE


Industry News: How Exercise Can Help You Live Longer

Apr 02
2014

Industry News: How Exercise Can Help You Live Longer

On April 2, 2014 the New York Times profiled research connecting exercise, independently, to reduced risk of a heart attack. In a study done at Cutin University in Perth Australia, researchers examined the cause of death for sample population after gathering the participants’ Framingham Risk Scores, a calculation of the likelihood of experiencing a heart attack with in the next decade, 15 years prior. By dividing the study participants in three groups based on their amount of weekly exercise, the researchers found an independent link between exercise and decreased risk of a fatal heart attack.  This research was unique because…


View MoreREAD MORE


Board Member in the News: Scientific Director Steven Austad Comments on Diet Studies

Apr 01
2014

Board Member in the News: Scientific Director Steven Austad Comments on Diet Studies

On April 1, 2014, the New York Times featured AFAR’s Scientific Director Steven Austad in an article comparing the results of two studies on the effects of caloric restriction and longevity in rhesus monkeys. Starting in 1987, rival groups at the National Institute for Aging (NIA) in Baltimore and the University of Wisconsin used different research methodologies to study the effects of diet on health and longevity. The Wisconsin group, which allowed their control monkeys to eat unlimited qualities of not particularly healthy foods, found that calorie restriction reduced cases of diabetes, cancer, cardiovascular disease, and brain atrophy and resulted…


View MoreREAD MORE


Board Member in the News: Interview with Deputy Scientific Director Nir Barzilai

Apr 01
2014

Board Member in the News: Interview with Deputy Scientific Director Nir Barzilai

In March 2014, Medscape sat down with AFAR Board Member and Deputy Scientific Director Nir Barzilai, MD, to discuss the goals and implications of his Centenarian study. Dr. Barzilai expressed that the mission behind his longevity research was not to extend human lifespan, but rather to delay the onset of age-related disease. Dr. Barzilai’s study investigates healthy centenarians with a two-fold goal.  First, to sequence the genome of people with exceptional longevity, and second, to use information uncovered about gene function to develop medications that will potentially delay aging. Nir Barzilai, MD is a professor of…


View MoreREAD MORE




BACK TO TOPBACK TO TOP